BTI released shareholder update this AM:
http://app.quotemedia.com/quotetools/newsStoryPopup.go?storyId=38839059&topic=BTI:CA&symbology=null&cp=off&webmasterId=94743

7% concentration of therapeutics in the brain is spectacular. This is a great achievement by their BBB crossing technology.

Commercial development phase in 2011 underway....I expect the news roll to start soon.

TB
technicalbuy.com